Published Date: 03/15/2023
Expiration Date: 10/20/2023
In this presentation, Dr. Wiegand will delineate the differences between dependence and tolerance as it relates to opioid use. This training will provide an overview of opioid usage and its impact on adequate pain management. By the end of this training providers will be able to discuss ways to effectively manage pain use both opioid and non-opioid medications.
Effective June 27, 2023 the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a one-time requirement of 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for practitioners who are applying for or renewing their DEA license. This 1-hour ACCME-accredited course meets the DEA/SAMHSA requirement.
Tim Wiegand, MD is the Director of Toxicology and of the Toxicology & Addiction Consult Service at the University of Rochester Medical Center in Rochester, New York and he is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester School of Medicine & Dentistry, Rochester New York. He also serves as adjunct faculty and consultant toxicologist for the SUNY Upstate Poison Center and SUNY Upstate Medical Toxicology Fellowship Training Program. He is also the Medical Director for Huther Doyle, a New York OASAS-certified outpatient substance use disorder treatment program. He is a frequent lecturer locally, in New York, nationally, and internationally on the use of buprenorphine and on the treatment of opioid use disorder in the ED and hospital setting, on the treatment of pain and perioperative management for patients on buprenorphine and methadone, on drug testing during buprenorphine treatment, and on other topics related to addiction medicine and medical toxicology.